相似文献
1
Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about "Triple-negative breast cancer: treatment challenges and solutions" by Collignon et al.
Breast Cancer (Dove Med Press). 2016 Aug 19;8:157-9. doi: 10.2147/BCTT.S113577. eCollection 2016.
2
Androgen receptor and FOXA1 coexpression define a "luminal-AR" subtype of feline mammary carcinomas, spontaneous models of breast cancer.
BMC Cancer. 2019 Dec 30;19(1):1267. doi: 10.1186/s12885-019-6483-6.
3
Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
Tumour Biol. 2020 Jan;42(1):1010428319901052. doi: 10.1177/1010428319901052.
4
Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.
5
Claudin 4 expression in triple-negative breast cancer: correlation with androgen receptors and Ki-67 expression.
Ann Diagn Pathol. 2015 Feb;19(1):37-42. doi: 10.1016/j.anndiagpath.2014.10.003. Epub 2014 Oct 25.
6
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer.
NPJ Breast Cancer. 2017 Aug 18;3:29. doi: 10.1038/s41523-017-0038-2. eCollection 2017.
7
Targeting the androgen receptor in triple-negative breast cancer.
Curr Probl Cancer. 2016 Mar-Aug;40(2-4):141-150. doi: 10.1016/j.currproblcancer.2016.09.004. Epub 2016 Sep 20.
8
Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor-Positive Subset of Triple-Negative Breast Cancers.
Am J Surg Pathol. 2016 Aug;40(8):1109-16. doi: 10.1097/PAS.0000000000000671.
9
Expression and clinical significance of androgen receptor in triple negative breast cancer.
Chin J Cancer. 2010 Jun;29(6):585-90. doi: 10.5732/cjc.009.10673.
10
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in -associated and sporadic triple-negative breast cancer.
NPJ Breast Cancer. 2016 Feb 24;2:16002. doi: 10.1038/npjbcancer.2016.2. eCollection 2016.
引用本文的文献
1
High claudin-4 antigen expression in triple-negative breast cancer by the immunohistochemistry method.
J Res Med Sci. 2022 Mar 17;27:20. doi: 10.4103/jrms.jrms_1389_20. eCollection 2022.
2
Knockdown of long non-coding RNA CDKN2B-AS1 suppresses the progression of breast cancer by miR-122-5p/STK39 axis.
Bioengineered. 2021 Dec;12(1):5125-5137. doi: 10.1080/21655979.2021.1962685.
3
Association of caspase 8 polymorphisms -652 6N InsDel and Asp302His with progression-free survival and tumor infiltrating lymphocytes in early breast cancer.
Sci Rep. 2019 Aug 29;9(1):12594. doi: 10.1038/s41598-019-47601-x.
4
Kaempferol Suppresses Proliferation and Induces Cell Cycle Arrest, Apoptosis, and DNA Damage in Breast Cancer Cells.
Oncol Res. 2019 Jun 21;27(6):629-634. doi: 10.3727/096504018X15228018559434. Epub 2018 Apr 3.
5
Immunoexpression of lactoferrin in triple-negative breast cancer patients: A proposal to select a less aggressive subgroup.
Oncol Lett. 2017 May;13(5):3205-3209. doi: 10.3892/ol.2017.5859. Epub 2017 Mar 14.
本文引用的文献
1
Triple-negative breast cancer: treatment challenges and solutions.
Breast Cancer (Dove Med Press). 2016 May 20;8:93-107. doi: 10.2147/BCTT.S69488. eCollection 2016.
2
Androgen Receptor (AR), E-Cadherin, and Ki-67 as Emerging Targets and Novel Prognostic Markers in Triple-Negative Breast Cancer (TNBC) Patients.
PLoS One. 2015 Jun 3;10(6):e0128368. doi: 10.1371/journal.pone.0128368. eCollection 2015.
3
Is androgen receptor targeting an emerging treatment strategy for triple negative breast cancer?
Cancer Treat Rev. 2015 Jun;41(6):547-53. doi: 10.1016/j.ctrv.2015.04.009. Epub 2015 Apr 29.
4
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer.
Clin Cancer Res. 2013 Oct 1;19(19):5505-12. doi: 10.1158/1078-0432.CCR-12-3327. Epub 2013 Aug 21.
5
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer.
Clin Cancer Res. 2013 May 15;19(10):2723-33. doi: 10.1158/1078-0432.CCR-12-2986. Epub 2013 Apr 2.
6
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.
J Clin Invest. 2011 Jul;121(7):2750-67. doi: 10.1172/JCI45014.
Zotero 插件